Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Humanoid Robots Help Children with Autism Learn Interaction

Maja Mataric´(University of Southern California)

29 August 2014. Engineers and computer scientists at University of Southern California in Los Angeles show how commercial humanoid robots can help children with autism spectrum disorder learn basic social behavior. The team from the lab of Maja Mataric´, director of USC’s Robotics and Autonomous Systems Center, presented its . . . → Read More: Humanoid Robots Help Children with Autism Learn Interaction

Ebola Vaccine Safety Trials Scheduled in U.S., U.K., Africa

Ebola health care workers in Guinea (European Commission-ECHO/USAID)

28 August 2014. Early-stage clinical trials testing the safety of new vaccines to protect against the Ebola virus are scheduled to begin as early as next week at sites in the U.S., United Kingdom, Mali, and The Gambia in West Africa. The vaccines are being developed . . . → Read More: Ebola Vaccine Safety Trials Scheduled in U.S., U.K., Africa

Biotech, Universities to Test Hydrogel for Vocal Fold Scars

(A. Kotok)

28 August 2014. BioTime Inc., a biotechnology company in Alameida, California, is partnering with researchers at University of Wisconsin and Université catholique de Louvain in Belgium to test its hydrogels for treating vocal cord scarring, a voice problem that results from injury or disease. Financial terms of the collaboration were not disclosed.

. . . → Read More: Biotech, Universities to Test Hydrogel for Vocal Fold Scars

Smartphone App Screens Infants for Jaundice

Newborn being photographed with BiliCam color-calibration card (University of Washington)

27 August 2014. Computer scientists and medical researchers at University of Washington in Seattle are developing a system that lets physicians or parents with a smartphone screen newborn infants for jaundice. The system is described in a paper to be presented on 16 September . . . → Read More: Smartphone App Screens Infants for Jaundice

Ionic Liquids Shown to Combat Bacterial Biofilms

Pseudomonas aeruginosa bacteria (NIH)

27 August 2014. Researchers at Los Alamos National Lab in New Mexico developed a way to harness ionic liquids — salts in a liquid state — that in lab tests disrupt biofilms, antibiotic-resistant bacterial colonies, and boost treatments for skin infections. The team led by Los Alamos Lab’s David Fox . . . → Read More: Ionic Liquids Shown to Combat Bacterial Biofilms

Implant Developed to Measure Pressure Causing Glaucoma

(Photos8.com)

26 August 2014. Biomedical engineers at Stanford University in California and Bar-Ilan University in Israel designed an implanted device for people with glaucoma to take frequent and accurate measures of high pressure inside their eyes, a factor closely associated with glaucoma. The team led by Stanford bioengineering professor Stephen Quake and Bar-Ilan ophthalmologist . . . → Read More: Implant Developed to Measure Pressure Causing Glaucoma

University Starts Computer Science/Brain Research Consortium

3-D brain wiring illustration (NIH)

26 August 2014. Carnegie Mellon University in Pittsburgh organized an international consortium of researchers to apply computer science techniques to the study of brain research and behavior. The collaboration, known as BrainHub, includes researchers from nearby University of Pittsburgh, as well as Sun Yat-sen University in Guangzhou, China, Indian . . . → Read More: University Starts Computer Science/Brain Research Consortium

FDA Approves Low-Dose Anti-Inflammatory for Arthritis Pain

(NASA.gov)

25 August 2014. Iroko Pharmaceuticals LLC in Philadelphia says the U.S. Food and Drug Administration approved its low-dose formulation of the nonsteroidal anti-inflammatory drug diclofenac to treat pain from osteoarthritis. FDA in October 2013 already approved this drug, marketed under the name Zorvolex, as a treatment for mild to moderate pain in adults.

. . . → Read More: FDA Approves Low-Dose Anti-Inflammatory for Arthritis Pain

Trial Crowdsources Lung Cancer Biomarker Screening

(National Cancer Institute)

22 August 2014. A clinical trial at University of Colorado Cancer Center in Aurora is recruiting participants through an online campaign to find people with lung cancer that meet a specific genetic profile who would most likely respond to the drug being tested. The study is led by Ross Camidge, director . . . → Read More: Trial Crowdsources Lung Cancer Biomarker Screening

Extended Hemophilia Therapy Lowers Bleeding Rates in Trial

(National Institutes of Health)

22 August 2014. Results from a late-stage clinical trial show an extended-life therapy to control hemophilia reduces rates of bleeding among patients when used as a preventive medication. The biologic tested in the trial is an extended release version of Advate, an engineered form of blood coagulant proteins made by . . . → Read More: Extended Hemophilia Therapy Lowers Bleeding Rates in Trial